Investment Bank Ratings & Recommendations
Report Date: 2026-02-28
Key Takeaways
📈 Notable Upgrades 5 calls
NFLX
Netflix, Inc.
↑ Upgrade
Goldman Sachs • Eric Sheridan 📅 2026-02-28
Neutral Buy
Old PT 110
New PT 125
Current 96.24
29.9%
Password sharing crackdown accelerating subscriber growth beyond expectations, AI content optimization driving margin expansion
INTC
Intel Corporation
↑ Upgrade
JPMorgan • Harlan Sur 📅 2026-02-27
Underweight Neutral
Old PT 42
New PT 52
Current 45.61
14.0%
18A foundry process gaining customer traction, government subsidies de-risking capex investments
XLV
Healthcare Sector
↑ Upgrade
Morgan Stanley • Terence Flynn 📅 2026-02-26
Equal Weight Overweight
Old PT 165
New PT 175
Current 160.2
9.2%
Defensive qualities attractive amid market volatility, GLP-1 innovation cycle creating new growth vectors
ADBE
Adobe Inc.
↑ Upgrade
Wedbush • Daniel Ives 📅 2026-02-25
Neutral Outperform
Old PT 280
New PT 320
Current 262.41
22.0%
Firefly AI integration driving subscription upsell, enterprise demand accelerating post-COVID normalization
XLE
Energy Sector
↑ Upgrade
Bank of America • Kalei Akamine 📅 2026-02-24
Neutral Buy
Old PT 58
New PT 65
Current 55.92
16.3%
Oil supply constraints tightening, capex discipline driving free cash flow generation
📉 Notable Downgrades 4 calls
NVDA
NVIDIA Corporation
↓ Downgrade
UBS • Timothy Arcuri 📅 2026-02-28
Buy Neutral
Old PT 220
New PT 185
Current 177.19
-4.4%
AI capex cycle peaking, hyperscaler spending normalization creating demand headwinds
ORCL
Oracle Corporation
↓ Downgrade
Jefferies • Brent Thill 📅 2026-02-27
Buy Hold
Old PT 180
New PT 150
Current 145.4
-3.2%
Cloud transition momentum slowing, competitive pressure from hyperscalers intensifying
META
Meta Platforms, Inc.
↓ Downgrade
Wells Fargo • Ken Gawrelski 📅 2026-02-26
Overweight Equal Weight
Old PT 720
New PT 680
Current 648.18
-4.9%
Reality Labs losses accelerating, regulatory headwinds in EU impacting growth
XLF
Financial Sector
↓ Downgrade
Deutsche Bank • Matt O'Connor 📅 2026-02-25
Buy Hold
Old PT 58
New PT 52
Current 51.43
-1.1%
Net interest margin pressure from rate cuts, commercial real estate exposure concerns
⚖️ Sector Weight Changes 3 changes
Goldman Sachs 📅 2026-02-26
Healthcare
↑ UPGRADED
Neutral Overweight
Defensive characteristics attractive in volatile environment, innovation in obesity drugs creating new TAM
Top Picks
LLYNVOUNH
Avoid
BIIB
JPMorgan 📅 2026-02-24
Technology
↓ DOWNGRADED
Overweight Neutral
Valuation reset needed after AI euphoria, earnings growth moderating from peak levels
Top Picks
GOOGLAMZNADBE
Avoid
NVDA
Morgan Stanley 📅 2026-02-25
Energy
↑ UPGRADED
Underweight Neutral
Oil supply-demand rebalancing, capital discipline driving shareholder returns
Top Picks
XOMCVXCOP
Avoid
SLB
🎯 Thematic Calls 3 themes
AI Infrastructure Plateau
Bank of America 📅 2026-02-22
BEARISH
Hyperscaler capex cycle peaking as efficiency gains reduce incremental hardware needs, oversupply emerging in data center components
Beneficiaries
INTCAMD
At Risk
NVDASMCI
Timeframe: 6-12 months | Conviction: HIGH
Obesity Drug Revolution
Jefferies 📅 2026-02-20
BULLISH
GLP-1 adoption accelerating beyond diabetes into broader metabolic health, creating $200B+ TAM by 2030
Beneficiaries
LLYNVO
At Risk
WMTPEP
Timeframe: 3-5 years | Conviction: HIGH
China Reopening 2.0
Wells Fargo 📅 2026-02-18
BULLISH
Stimulus measures driving domestic consumption recovery, property sector stabilizing
Beneficiaries
BABANIOLI
At Risk
NFLXDIS
Timeframe: 12-18 months | Conviction: MEDIUM
🌍 Market Allocation
Overall Market View
Equities Cautiously optimistic - late cycle dynamics with pockets of value emerging
Bonds Neutral - duration risk balanced by attractive yields
Cash Hold 5-10% cash for opportunities
Regional Preferences
US Neutral weight - expensive but quality remains
Europe Underweight - structural headwinds persist
Emerging Markets Overweight - attractive valuations
China Neutral - selective opportunities emerging
Japan Overweight - corporate reforms driving returns
Style Preferences
Growth Vs Value Neutral tilt to value - growth premium compressing
Large Vs Small Overweight large cap - quality bias in uncertain environment
Cyclical Vs Defensive Balanced - selective cyclical exposure with defensive anchor
💡 Actionable Ideas 1 ideas
Long Healthcare (XLV) vs Short Technology (XLK) pairs trade
Defensive rotation accelerating, healthcare valuations attractive relative to tech premium
Supported by: Morgan Stanley, Goldman Sachs, Bank of America
⚠️ Risk: Risk-on sentiment returning could favor growth over defensive